Inside Out: LLY and the Future of Weight Loss Drugs
Community Score: 50% | 27 views | 1w
0 community ratings: null thumbs up, null thumbs down
Matt Tuttle can't quite pronounce the name of Eli Lilly's (LLY) oral weight-loss drug, but that doesn't stop him from understanding its significance to the healthcare company's future. He reacts to the increased attention on the overall sector and compares LLY to other names like Hims & Hers (HIMS). Later, Tom White composes a put vertical example options strategy for LLY. ======== Schwab Network ======== Empowering every investor and trader, every market day. Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6D Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185 Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7 Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch Watch on Vizio - https://www.vizio.com/en/watchfreeplu
More from Schwab Network
- META's Path to $800: Jason Ware Sees Bull Case in AI ROI as CapEx Grows — Score: 50%
- "Tale of Two Chinas:" Hot AI Trade Meets Cooling Consumer Activity — Score: 50%
- Stock Market Today: MU Hits Highs, QCOM Deal & AAPL Falls — Score: 50%
- Strive CRO on Bitcoin's Buy Opportunity, Crypto Volatility & SATA — Score: 50%
- Thursday’s Final Takeaways: PCE, Markets & Tech in Focus — Score: 50%
- Bitcoin Breaks Key Technical Level as Crypto Awaits Regulatory Clarity — Score: 50%